TD Asset Management’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-51,600
| Closed | -$817K | – | 1242 |
|
|
2024
Q4 | $817K | Buy |
+51,600
| New | +$817K | ﹤0.01% | 1136 |
|
|
2023
Q4 | – | Sell |
-36,200
| Closed | -$1.15M | – | 1420 |
|
|
2023
Q3 | $1.15M | Buy |
36,200
+18,100
| +100% | +$577K | ﹤0.01% | 1107 |
|
|
2023
Q2 | $727K | Hold |
18,100
| – | – | ﹤0.01% | 1194 |
|
|
2023
Q1 | $773K | Buy |
18,100
+8,100
| +81% | +$346K | ﹤0.01% | 1185 |
|
|
2022
Q4 | $480K | Buy |
+10,000
| New | +$480K | ﹤0.01% | 1293 |
|